A cell permeable peptide inhibitor of NFAT inhibits macrophage cytokine expression and ameliorates experimental colitis
about
Calcineurin/NFAT signaling and innate host defence: a role for NOD1-mediated phagocytic functionsThe transcription factor nuclear factor of activated T cells c3 modulates the function of macrophages in sepsis.Calcineurin/NFAT signaling represses genes Vamp1 and Vamp2 via PMCA-dependent mechanism during dopamine secretion by Pheochromocytoma cells.Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.NFAT as cancer target: mission possible?Inhibiting NFAT1 for breast cancer therapy: New insights into the mechanism of action of MDM2 inhibitor JapAThe Sur1-Trpm4 channel regulates NOS2 transcription in TLR4-activated microglia.Inducible nitric oxide synthase (NOS-2) in subarachnoid hemorrhage: Regulatory mechanisms and therapeutic implications.Calcineurin-NFAT signalling in myeloid leucocytes: new prospects and pitfalls in immunosuppressive therapy.Short peptides interfering with signaling pathways as new therapeutic tools for cancer treatment.Specific calcineurin targeting in macrophages confers resistance to inflammation via MKP-1 and p38The calcineurin-NFAT-angiopoietin-2 signaling axis in lung endothelium is critical for the establishment of lung metastases.Intrinsic disorder within AKAP79 fine-tunes anchored phosphatase activity toward substrates and drug sensitivityThe Origins and Functions of Tissue-Resident Macrophages in Kidney Development.Inhibition of nuclear factor of activated T cells (NFAT) c3 activation attenuates acute lung injury and pulmonary edema in murine models of sepsis.Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease.
P2860
Q26861114-C7EAE64D-5836-451E-ADA8-5E8C1EACC770Q34364408-7FB3354F-099B-4B48-A6BD-F59663BE801FQ35131056-2FCC5826-3ACC-4C95-BFD8-8901D0B63316Q35820373-90C423EC-7E88-4917-A8FA-7FCBD66DAE57Q36455193-1ABDAAF6-A5FF-45B2-A57E-1BF699F005DAQ36545083-D06088BA-52C9-4911-871D-8F6A5C9F258BQ36955393-1B17D5BF-C7E6-4D7D-92D6-B1CAD1F5B6EBQ37357824-253F5ED5-2591-42E2-B786-E173FF761A0EQ38729042-5EA590B0-80CD-4A5F-8057-033765D2CC5FQ38767147-1CC4563A-7461-46F3-A006-6C75BA745A9EQ39018487-10920D9F-1D87-41D7-BD3D-BFD6E4D88902Q39108835-B5622D88-84D2-47E8-910E-0E05AB241B13Q42648353-F699ECF2-230D-46E6-B39F-BD2F69239A0BQ47152801-E015B6E5-DD32-4B29-A8BD-006BD6D8EBD6Q53079272-C36717CA-421C-44D6-A1A4-7E21210E248AQ55068395-8E345DFE-2D9C-4311-ACF4-041F4F67D0B3
P2860
A cell permeable peptide inhibitor of NFAT inhibits macrophage cytokine expression and ameliorates experimental colitis
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A cell permeable peptide inhib ...... eliorates experimental colitis
@ast
A cell permeable peptide inhib ...... eliorates experimental colitis
@en
A cell permeable peptide inhib ...... eliorates experimental colitis
@nl
type
label
A cell permeable peptide inhib ...... eliorates experimental colitis
@ast
A cell permeable peptide inhib ...... eliorates experimental colitis
@en
A cell permeable peptide inhib ...... eliorates experimental colitis
@nl
prefLabel
A cell permeable peptide inhib ...... eliorates experimental colitis
@ast
A cell permeable peptide inhib ...... eliorates experimental colitis
@en
A cell permeable peptide inhib ...... eliorates experimental colitis
@nl
P2093
P2860
P1433
P1476
A cell permeable peptide inhib ...... eliorates experimental colitis
@en
P2093
Christian Jobin
Fengling Li
Houda Z Elloumi
Hyungjin S Ryu
Kavitha N Rao
Marcus Mühlbauer
Nitsan Maharshak
Scott E Plevy
Taku Kobayashi
P2860
P304
P356
10.1371/JOURNAL.PONE.0034172
P407
P577
2012-03-27T00:00:00Z